The levels of CCL-2 were reported to be elevated in COVID-19 patients compared to healthy individuals, especially those infected with ancestral, alpha, and omicron SARS-CoV-2 variants (Huang et al., 2020; Zhao et al., 2020; Korobova et al., 2022). Here, CCL2 is linked to COVID-19.